Clinical Trial Update: Psilocybin Therapy for Depression in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin therapy for depression in Parkinson's disease is currently recruiting. The study investigates psilocybin as a poten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Joshua Woolley, MD, PhD | Conditions: Parkinson Disease, Depression | Phase 2 | Status: RECRUITING